Clearance Summary
DADE (PAI-1) CHROMOGENIC ASSAY DADE COAGTROL-PAI received FDA 510(k) clearance under submission number K933188, sponsored by Baxter Diagnostics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1993-09-22.
- Submission: K933188
- Applicant / Sponsor: Baxter Diagnostics, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.5425
- Decision date: 1993-09-22
Classification & Regulation
This clearance is catalogued under FDA product code JPA and 21 CFR 864.5425, within the Hematology review panel as a Class II device.